(Q40884693)
Statements
Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial (English)
Marc S Sabatine
Anthony Keech
Narimon Honarpour
Huei Wang
Thomas Liu
Scott M Wasserman
Robert Scott
Peter S Sever